Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Title: A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant

ABSTRACT: a broad range of SARS-CoV-2 inhibitor

PROVIDER: PRJEB50508 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR8262070_1.fastq.gz	Fastqsanger.gz
	ERR8262070_2.fastq.gz	Fastqsanger.gz
	ERR8262071_1.fastq.gz	Fastqsanger.gz
	ERR8262071_2.fastq.gz	Fastqsanger.gz
	ERR8262052_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.

Project description:The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants has altered the trajectory of the COVID-19 pandemic and raised some uncertainty on the long-term efficiency of vaccine strategy. The development of new therapeutics against a wide range of SARS-CoV-2 variants is imperative. We, here, have designed an inhalable siRNA, C6G25S, which covers 99.8% of current SARS-CoV-2 variants and is capable of inhibiting dominant strains, including Alpha, Delta, Gamma, and Epsilon, at picomolar ranges of IC50 in vitro. Moreover, C6G25S could completely inhibit the production of infectious virions in lungs by prophylactic treatment, and decrease 96.2% of virions by cotreatment in K18-hACE2-transgenic mice, accompanied by a significant prevention of virus-associated extensive pulmonary alveolar damage, vascular thrombi, and immune cell infiltrations. Our data suggest that C6G25S provides an alternative and effective approach to combating the COVID-19 pandemic.

| S-EPMC8988202 | biostudies-literature

A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant

Project description:The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants has altered the trajectory of the COVID-19 pandemic and raised some uncertainty on long term efficiency of vaccine strategy. The development of new therapeutics against a wide range of SARS-CoV-2 variants is imperative. We here have designed an inhalable siRNA, C6G25S, which covers 99.8% of current SARS-CoV-2 variants and is capable of inhibiting dominant strains, including Alpha, Delta, Gamma and Epsilon, at picomolar ranges of IC50 in vitro. Moreover, C6G25S could completely inhibit the production of infectious virions in lungs by prophylactic treatment, and decrease 96.2% of virions by co-treatment in K18-hACE2-transgenic mice, accompanying with a significant prevention of virus-associated extensive pulmonary alveolar damage, vascular thrombi, and immune cell infiltrations. Our data suggests that C6G25S provides an alternative and effective approach to combating the COVID-19 pandemic.

| S-SCDT-EMM-2021-15298 | biostudies-other

Sequence of the broad host-range IncP-alpha plasmid pRK404G

Project description:Re-sequencing of the broad host-range IncP-alpha plasmid pRK404

| PRJEB36160 | ENA

Broad-range Amplification and Sequencing of the rpoB Gene: A Novel Assay for Bacterial Identification in Clinical Microbiology

Project description:Broad-range Amplification and Sequencing of the rpoB Gene

| PRJEB75571 | ENA

Permissive epigenomic states endow reprogramming competence to a broad range of transcriptional regulators

Project description:Permissive epigenomic states endow reprogramming competence to a broad range of transcriptional regulators

| PRJNA627156 | ENA

Drug-induced metabolic remodeling of immune cell repertoire generates an effective broad-range antimicrobial effect

Project description:Drug-induced metabolic remodeling of immune cell repertoire generates an effective broad-range antimicrobial effect

| PRJNA1259990 | ENA

Microglia P2Y6 receptor signaling regulates a broad range of innate immune responses after TLR engagement

Project description:Microglia P2Y6 receptor signaling regulates a broad range of innate immune responses after TLR engagement

| PRJNA802378 | ENA

Transcriptome analysis of the broad-host range pathogen Pythium myriotylum during infection of ginger (Zingiberis officinale) leaves.

Project description:Oomycetes, such as the broad host-range necrotrophic plant pathogen Pythium myriotylum, cause devastating crop losses. We have previously identified P. myriotylum as the major pathogen infecting ginger (Zingiber officinale) rhizomes in China with symptoms of Pythium soft rot (PSR) disease. Ginger is an important crop with global production estimated at approximately three million metric tonnes with about 20% of this production in China. To better understand how P. myriotylum infects ginger, transcriptomic analysis was performed on two P. myriotylum isolates (SWQ7 and SL2) infecting ginger leaves. From both of the isolates, there was a clear separation between the transcriptome replicates from the mycelial control condition and those from the infection of the ginger leaf. In SWQ7 and SL2, there were 2,110 and 2,513 genes upregulated during infection of ginger, respectively. Of the putative effectors, a subset of the NEP1-like toxin protein (NLP) effectors were highly induced during the infection of ginger leaves. Insights from the transcriptome highlight the important role of a subset of plant cell wall degrading enzymes (PCWDEs) and effectors in the pathogenicity of P. myriotylum towards ginger. The surprisingly large numbers of P. myriotylum PCWDEs and effectors within the genome may be due to the broad host-range of P. myriotylum whereby particular subsets of the PCWDEs and effectors are required for pathogenicity towards particular hosts.

2022-07-22 | GSE174557 | GEO

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses.

Project description:The SARS-CoV-2 Delta variant is currently responsible for most infections worldwide, including among fully vaccinated individuals. Although these latter infections are associated with milder COVID-19 disease relative to unvaccinated subjects, the specificity and durability of antibody responses elicited by Delta breakthrough cases remain unknown. Here, we demonstrate that breakthrough infections induce serum binding and neutralizing antibody responses that are markedly more potent, durable and resilient to spike mutations observed in variants of concern than those observed in subjects who were infected only or received only two doses of COVID-19 vaccine. However, wee show that Delta breakthrough cases, subjects who were vaccinated after SARS-CoV-2 infection and individuals vaccinated three times (without infection) have serum neutralizing activity of comparable magnitude and breadth indicate that multiple types of exposure or increased number of exposures to SARS-CoV-2 antigen(s) enhance spike-specific antibody responses. Neutralization of the genetically divergent SARS-CoV, however, was moderate with all four cohorts examined, except after four exposures to the SARS-CoV-2 spike, underscoring the importance of developing vaccines eliciting broad sarbecovirus immunity for pandemic preparedness.

| S-EPMC8687475 | biostudies-literature

γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges

Project description:γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges

| PRJNA1055039 | ENA